Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuejun Chen

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2026
Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified managementChang Yuan, Chunji Chen, Zhichao Liu, et al.
JAMA Oncology|March 1, 2019
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene PanelZhijie Wang, Jianchun Duan, Shangli Cai, et al.
The New England Journal of Medicine|July 8, 2026
Ensartinib in Resected <i>ALK</i>-Positive Non-Small-Cell Lung CancerDongsheng Yue, Meijuan Huang, Pingping Song, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2026
Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified managementChang Yuan, Chunji Chen, Zhichao Liu, et al.
JAMA Oncology|March 1, 2019
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene PanelZhijie Wang, Jianchun Duan, Shangli Cai, et al.
The New England Journal of Medicine|July 8, 2026
Ensartinib in Resected <i>ALK</i>-Positive Non-Small-Cell Lung CancerDongsheng Yue, Meijuan Huang, Pingping Song, et al.
Pageof 6